Yuzhang Liu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CM313 Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma or Marginal Zone Lymphoma: A Multicenter, Phase 1 Dose-Escalation and Dose-Expansion Trial.
Journal: American journal of hematology
Published: September 05, 2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma.
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma.
Journal: Cancer medicine
Published: November 21, 2023
Low-dose decitabine plus bortezomib-dexamethasone therapy is well-tolerated and highly effective on first-relapsed multiple myeloma: a single-center phase 2 trial.
Journal: American journal of cancer research
Published: February 16, 2023
Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study.
Journal: Annals of palliative medicine
Published: September 30, 2021
miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition.
Journal: International journal of cancer
Published: September 14, 2020
miR-144-3p Suppresses Osteogenic Differentiation of BMSCs from Patients with Aplastic Anemia through Repression of TET2.
Journal: Molecular therapy. Nucleic acids
Published: April 22, 2019
The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma.
Journal: Acta haematologica
Published: December 12, 2018
Comparative Analysis of miRNA Expression Profiles of Multiple Myeloma with 1q21 Gains and Normal FISH.
Journal: Acta haematologica
Published: July 28, 2017
Treatment of relapsed and refractory acute lymphocytic leukemia by modified CAG regimen
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: April 21, 2016
Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy.
Journal: International journal of general medicine
Published: June 26, 2015
Bortezomib in combination with dexamethasone in the treatment of multiple myeloma induced rhabdomyolysis: a case report
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: April 10, 2015
Last Updated: 09/26/2026